Sean P. David, M.D., D.Phil.

Family medicine doctor

Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center
I am a family doctor and physician scientist interested in translational research to improve preventive health and public health strategies to improve population health. Born and raised in Seattle, I love the west and Pac-12 football, fishing, marathon running and rowing.

Express Care

  • 211 Quarry Road
  • Palo Alto, CA 94304
  • Phone: 650-736-5211
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Professional Education: University of Oxford (2006) UK

Residency: NH Dartmouth Family Practice Residency (1998) NH

Medical Education: University of Washington School of Medicine (1995) WA

BS, University of Washington, Zoology (1990)

SM, Harvard School of Public Health, Health & Social Behavior (1999)

Internship: NH Dartmouth Family Practice Residency (1996) NH

Fellowship, Cancer Research UK GPRG, University of Oxford, Genetics (2002)

Board Certification: Family Medicine, American Board of Family Medicine (1998)

Board Certification, ABFM, Family Medicine (2005)

Honors & Awards

Board of US BMJ Fellows, BMJ Group (2013)

James C. Puffer, M.D./American Board of Family Medicine/Insitute of Medicine Anniversary Fellow, Institute of Medicine (2011-2013)

Benjamin Meaker Visiting Professorship, University of Bristol (2010)

Family Practice Scholar Award, Glaxo-Wellcome (1997)

Dean’s Teaching Excellence Award, Brown Alpert Medical School (2001)

Profiles in Competence Teaching Award, Brown Alpert Medical School (2002)

Advanced Research Training Award, American Academy of Family Physicians (2001-2003)

Generalist Physician Faculty Scholars Award, Robert Wood Johnson Foundation (2002-2006)

K08 Mentored Clinical Scientist Development Award, National Institute on Drug Abuse/National Institutes of Health (2002-2008)

MCR President, Green College, University of Oxford (2004-2005)

Administrative Appointments

Clinical Associate Professor of Family & Community Medicine, Stanford University School of Medicine (2009 - Present)

Physician curator, PharmGKB (2010 - 2011)

Clinical Associate Professor (secondary appointment), Stanford Prevention Research Center (2011 - Present)

Adjunct Associate Professor of Family Medicine, Brown Alpert Medical School (2009 - Present)

Director of Primary Care Genetics Laboratory & Translational Research Center, Memorial Hospital of Rhode Island/Brown Alpert Medical School (2002 - 2009)

Director of C. Everett Koop Health Policy Fellowship, Brown Alpert Medical School (2003 - 2009)

Assistant Professor of Family Medicine, Brown Alpert Medical School (2001 - 2009)

Instructor of Family Medicine, Brown Alpert Medical School (1999 - 2001)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Association of CHRNA5-A3-84 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers
Zhu, A. Zx., Zhou, Q., Cox, L. S., David, S. P., Ahluwalia, J. S., & Tyndale, R. F. (2014). Association of CHRNA5-A3-84 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers. CLINICAL PHARMACOLOGY & THERAPEUTICS, 96(2), 256-265.

Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.
Xu, X., Clark, U. S., David, S. P., Mulligan, R. C., Knopik, V. S., & Sweet, L. H. (2014). Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine & tobacco research , 16(7), 939-947.

Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders
Fusar-Poli, P., Radua, J., Frascarelli, M., Mechelli, A., Borgwardt, S., & David, S. P. (2014). Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. HUMAN BRAIN MAPPING, 35(7), 3052-3065.

Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention
Ioannidis, J. Pa., Munafo, M. R., Fusar-Poli, P., Nosek, B. A., & David, S. P. (2014). Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. TRENDS IN COGNITIVE SCIENCES, 18(5), 235-241.

Clinical interpretation and implications of whole-genome sequencing.
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA-the journal of the American Medical Association, 311(10), 1035-1045.

Clinical Interpretation and Implications of Whole-Genome Sequencing
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical Interpretation and Implications of Whole-Genome Sequencing. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 311(10), 1035-1044.

Systematic review and meta-analysis of opioid antagonists for smoking cessation.
David, S. P., Chu, I. M., Lancaster, T., Stead, L. F., Evins, A. E., & Prochaska, J. J. (2014). Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ open, 4(3).

Tobacco dependence treatment teaching by medical school clerkship preceptors: Survey responses from more than 1000 US medical students
Geller, A. C., Hayes, R. B., Leone, F., Churchill, L. C., Leung, K., & Ockene, J. K. (2013). Tobacco dependence treatment teaching by medical school clerkship preceptors: Survey responses from more than 1000 US medical students. PREVENTIVE MEDICINE, 57(2), 81-86.

Potential Reporting Bias in fMRI Studies of the Brain
David, S. P., Ware, J. J., Chu, I. M., Loftus, P. D., Fusar-Poli, P., & Ioannidis, J. Pa. (2013). Potential Reporting Bias in fMRI Studies of the Brain. PLOS ONE, 8(7).

Biomarkers for smoking cessation.
Bough, K. J., Lerman, C., Rose, J. E., McClernon, F. J., Kenny, P. J., & Amur, S. (2013). Biomarkers for smoking cessation. Clinical pharmacology & therapeutics, 93(6), 526-538.

Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study
McClure, J. B., Swan, G. E., St John, J., Fauver, R., Javitz, H. S., & David, S. P. (2013). Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study. NICOTINE & TOBACCO RESEARCH, 15(2), 518-526.

Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders.
Fusar-Poli, P., Joaquim, R., Marianna, F., Andrea, M., Stefan, B., & David, S. P. (2013). Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Human Brain Mapping.

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion
David, S. P., Strong, D. R., Leventhal, A. M., Lancaster, M. A., McGeary, J. E., & Niaura, R. (2013). Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction, 108(12).

Opioid antagonists for smoking cessation
David, S. P., Lancaster, T., Stead, L. F., Evins, A. E., & Prochaska, J. J. (2013). Opioid antagonists for smoking cessation. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6).

PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6
McDonagh, E. M., Wassenaar, C., David, S. P., Tyndale, R. F., Altman, R. B., & Klein, T. E. (2012). PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. PHARMACOGENETICS AND GENOMICS, 22(9), 695-708.

Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry-A Meta-Analysis of Chromosome 15q25
Chen, L.-S., Saccone, N. L., Culverhouse, R. C., Bracci, P. M., Chen, C.-H., & Bierut, L. J. (2012). Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry-A Meta-Analysis of Chromosome 15q25. GENETIC EPIDEMIOLOGY, 36(4), 340-351.

Genome-wide meta-analyses of smoking behaviors in African Americans
David, S. P., Hamidovic, A., Chen, G. K., Bergen, A. W., Wessel, J., & Furberg, H. (2012). Genome-wide meta-analyses of smoking behaviors in African Americans. TRANSLATIONAL PSYCHIATRY, 2.

The neuroeconomics of nicotine dependence: A preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers
MacKillop, J., Amlung, M. T., Wier, L. M., David, S. P., Ray, L. A., & Sweet, L. H. (2012). The neuroeconomics of nicotine dependence: A preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. PSYCHIATRY RESEARCH-NEUROIMAGING, 202(1), 20-29.

Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers
Liu, T., David, S. P., Tyndale, R. F., Wang, H., Yu, X.-Q., & Chen, W.-Q. (2012). Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers. ANNALS OF BEHAVIORAL MEDICINE, 43(2), 253-261.

Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence
Dewey, F. E., Chen, R., Cordero, S. P., Ormond, K. E., Caleshu, C., & Ashley, E. A. (2011). Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence. PLOS GENETICS, 7(9).

Associations of CYP2A6 genotype with smoking behaviors in southern China
Liu, T., David, S. P., Tyndale, R. F., Wang, H., Zhou, Q., & Chen, W.-Q. (2011). Associations of CYP2A6 genotype with smoking behaviors in southern China. ADDICTION, 106(5), 985-994.

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement
Uhl, G. R., Drgon, T., Johnson, C., Walther, D., Aveyard, P., & Munafo, M. R. (2010). Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. PHARMACOGENOMICS, 11(3), 357-367.

Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans
David, S. P., Mezuk, B., Zandi, P. P., Strong, D., Anthony, J. C., & Eaton, W. W. (2010). Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. NICOTINE & TOBACCO RESEARCH, 12(3), 251-262.

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses
David, S. P., Johnstone, E. C., Murphy, M. Fg., Aveyardd, P., Guo, B., & Munafo, M. R. (2008). Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses. DRUG AND ALCOHOL DEPENDENCE, 98(1-2), 77-85.

Genetic variation in the dopamine pathway and smoking cessation
David, S. P., & Munafo, M. R. (2008). Genetic variation in the dopamine pathway and smoking cessation. PHARMACOGENOMICS, 9(9), 1307-1321.

Molecular genetics of successful smoking cessation - Convergent genome-wide association study results
Uhl, G. R., Liu, Q.-R., Drgon, T., Johnson, C., Walther, D., & Rose, E. (2008). Molecular genetics of successful smoking cessation - Convergent genome-wide association study results. ARCHIVES OF GENERAL PSYCHIATRY, 65(6), 683-693.

Smoking cessation in primary care
David, S. P., & Munafo, M. R. (2008). Smoking cessation in primary care. BRITISH MEDICAL JOURNAL, 336(7655), 1200-1201.

Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
David, S. P., Munafo, M. R., Murphy, M. Fg., Proctor, M., Walton, R. T., & Johnstone, E. C. (2008). Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. PHARMACOGENOMICS JOURNAL, 8(2), 122-128.

Smoking cessation.
Koplan, K. E., David, S. P., & Rigotti, N. A. (2008). Smoking cessation. BMJ (Clinical research ed.), 336(7637), 217-?.

Teaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial.
Hayes, R. B., Geller, A., Churchill, L., Jolicoeur, D., Murray, D. M., & Ockene, J. K. (2014). Teaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Contemporary clinical trials, 37(2), 284-293.

Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation?
David, S. P. (2014). Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation?. ADDICTION, 109(1), 138-139.

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.
David, S. P., Strong, D. R., Leventhal, A. M., Lancaster, M. A., McGeary, J. E., & Niaura, R. (2013). Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction , 108(12), 2202-2211.

Communities of Solution: Partnerships for Population Health
Griswold, K. S., Lesko, S. E., & Westfall, J. M. (2013). Communities of Solution: Partnerships for Population Health. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 26(3), 232-238.

CHRONIC STRESS & SALIVARY BIOMARKERS
Mallick, A., Bergen, A., Nishita, D., Wei, X., Michel, M., & Andrews, J. (2013). CHRONIC STRESS & SALIVARY BIOMARKERS. JOURNAL OF INVESTIGATIVE MEDICINE, 61(1), 141-141.

Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers
Liu, T., Tyndale, R. F., David, S. P., Wang, H., Yu, X.-Q., & Chen, W.-Q. (2013). Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers. JOURNAL OF HUMAN HYPERTENSION, 27(1), 24-30.

No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.
Passarelli, M. N., Newcomb, P. A., Makar, K. W., Burnett-Hartman, A. N., Phipps, A. I., & Peters, U. (2013). No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause (New York, N.Y.).

Improving America's health requires community-level solutions: Folsom revisited.
Improving America's health requires community-level solutions: Folsom revisited. (2012). Improving America's health requires community-level solutions: Folsom revisited. American family physician, 86(4), 1-2.

Chronic psychosocial stressors and salivary biomarkers in emerging adults
Bergen, A. W., Mallick, A., Nishita, D., Wei, X., Michel, M., & Andrews, J. A. (2012). Chronic psychosocial stressors and salivary biomarkers in emerging adults. PSYCHONEUROENDOCRINOLOGY, 37(8), 1158-1170.

Communities of Solution: The Folsom Report Revisited
Lesko, S., Griswold, K. S., David, S. P., Bazemore, A. W., Duane, M., & Green, L. A. (2012). Communities of Solution: The Folsom Report Revisited. ANNALS OF FAMILY MEDICINE, 10(3), 250-260.

Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation
Leventhal, A. M., David, S. P., Brightman, M., Strong, D., McGeary, J. E., & Niaura, R. (2012). Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. PHARMACOGENOMICS JOURNAL, 12(1), 86-92.

Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women
Janes, A. C., Smoller, J. W., David, S. P., Frederick, B. B., Haddad, S., & Kaufman, M. J. (2012). Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. DRUG AND ALCOHOL DEPENDENCE, 120(1-3), 7-13.

Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways
Liu, T., Chen, W.-Q., David, S. P., Tyndale, R. F., Wang, H., & Ling, W.-H. (2011). Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 165(6), 961-967.

Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials
David, S. P., Johnstone, E. C., Churchman, M., Aveyard, P., Murphy, M. Fg., & Munafo, M. R. (2011). Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials. NICOTINE & TOBACCO RESEARCH, 13(3), 157-?.

Effects of nicotine withdrawal on verbal working memory and associated brain response
Sweet, L. H., Mulligan, R. C., Finnerty, C. E., Jerskey, B. A., David, S. P., & Niaura, R. S. (2010). Effects of nicotine withdrawal on verbal working memory and associated brain response. PSYCHIATRY RESEARCH-NEUROIMAGING, 183(1), 69-74.

Application of Functional Neuroimaging Methods to Nicotine Dependence.
David SP., Sweet L, Cohen R, MacKillop J, Mulligan RC, & Niaura R. (2010). Application of Functional Neuroimaging Methods to Nicotine Dependence. In: Brain Imaging in Behavioral Medicine and Neuropsychology. Edited by Cohen R. Springer, New York, NY, USA. (text book in press)..

Dopamine Transporters: Chemistry, Biology, and Pharmacology.
David SP. (2009). Dopamine Transporters: Chemistry, Biology, and Pharmacology. Clin Pharmacol Ther., 85(1).

Lifestyle Medicine by Gary Egger, Andrew Binns, and Stephen Rossner.
David SP. (2009). Lifestyle Medicine by Gary Egger, Andrew Binns, and Stephen Rossner. Am J Lifestyle Med., 3(9).

Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data
Munafo, M. R., Timpson, N. J., David, S. P., Ebrahim, S., & Lawlor, D. A. (2009). Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data. NICOTINE & TOBACCO RESEARCH, 11(1), 64-76.

[Smoking cessation].
Koplan, K. E., David, S. P., & Rigotti, N. A. (2008). [Smoking cessation]. Praxis, 97(22), 1185-1186.

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation
Welton, N. J., Johnstone, E. C., David, S. P., & Munafo, M. R. (2008). A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. NICOTINE & TOBACCO RESEARCH, 10(1), 231-240.

Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: A diffusion tensor imaging study
Paul, R. H., Grieve, S. M., Niaura, R., David, S. P., Laidlaw, D. H., & Gordon, E. (2008). Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: A diffusion tensor imaging study. NICOTINE & TOBACCO RESEARCH, 10(1), 137-147.

Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study
David, S. P., Munafo, M. R., Johansen-Berg, H., MacKillop, J., Sweet, L. H., & Walton, R. T. (2007). Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. BRAIN IMAGING AND BEHAVIOR, 1(3-4), 43-57.

Successful Latino community partnership program for smoking cessation
David, S. P., Smith, M., Lee, C. S., & Sullivan, G. (2007). Successful Latino community partnership program for smoking cessation. AMERICAN JOURNAL OF PUBLIC HEALTH, 97(8), 1348-1349.

Association of COMT Val(108/158) met genotype with smoking cessation in a nicotine replacement therapy randomized trial
Johnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. Fg., Walton, R. T., & Munafo, M. R. (2007). Association of COMT Val(108/158) met genotype with smoking cessation in a nicotine replacement therapy randomized trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 16(6), 1065-1069.

The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial
David, S. P., Munafo, M. R., Murphy, M. Fg., Walton, R. T., & Johnstone, E. C. (2007). The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial. NICOTINE & TOBACCO RESEARCH, 9(2), 225-231.

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation
David, S. P., Brown, R. A., Papandonatos, G. D., Kahler, C. W., Lloyd-Richardson, E. E., & Niaura, R. (2007). Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. NICOTINE & TOBACCO RESEARCH, 9(8), 821-833.

Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study.
David, S. P., Munafò, M. R., Johansen-Berg, H., Mackillop, J., Sweet, L. H., & Walton, R. T. (2007). Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain imaging and behavior, 1(3-4), 43-57.

Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials
David, S. P., Strong, D. R., Munafo, M. R., Brown, R. A., Lloyd-Richardson, E. E., & Niaura, R. (2007). Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials. NICOTINE & TOBACCO RESEARCH, 9(12), 1251-1257.

Building a successful research enterprise in family medicine: the Brown experience.
David, S. P., Eaton, C. B., Culpepper, L., Goldman, R. E., Lavallee, L. K., & Simmons, E. M. (2006). Building a successful research enterprise in family medicine: the Brown experience. Medicine and health, Rhode Island, 89(8), 281-284.

Fellowship training in family medicine at Brown: adding depth to breadth.
Long, R., David, S. P., Monroe, A., & Shaw, J. (2006). Fellowship training in family medicine at Brown: adding depth to breadth. Medicine and health, Rhode Island, 89(8), 274-275.

Studies of Genetic Influences on Nicotine Dependence Utilising Functional Neuroimaging.
David SP. (2006). Studies of Genetic Influences on Nicotine Dependence Utilising Functional Neuroimaging. Doctoral thesis: University of Oxford, Bodleian Library, Oxford, UK..

Opioid antagonists for smoking cessation
David, S., Lancaster, T., Stead, L. F., & Evins, A. E. (2006). Opioid antagonists for smoking cessation. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4).

The Pharmacogenetics of Nicotine Addiction and Smoking Cessation.
David SP., Munaf_ M, & Walton RT. (2006). The Pharmacogenetics of Nicotine Addiction and Smoking Cessation. Chapter 21 in: Pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine. Edited by Wong SHY, Linder MW, Valdes, Jr. R. AACC Press, Washington, DC..

Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study
David, S. P., Munafo, M. R., Johansen-Berg, H., Smith, S. M., Rogers, R. D., & Walton, R. T. (2005). Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study. BIOLOGICAL PSYCHIATRY, 58(6), 488-494.

A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans
David, S. P., Murthy, N. V., Rabiner, E. A., Munafo, M. R., Johnstone, E. C., & Grasby, P. M. (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. JOURNAL OF NEUROSCIENCE, 25(10), 2586-2590.

Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians.
David, S. P., Eaton, C. B., Taylor, J. S., Stamp, M. J., Cyr, M., & Walton, R. (2004). Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. Medicine and health, Rhode Island, 87(11), 336-340.

Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients?
Gramling, R., Duffy, C., & David, S. (2004). Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients?. GENETICS IN MEDICINE, 6(6), 542-542.

Investigating subgroups in smoking cessation treatment response: Response to Perkins
Munafo, M. R., Bradburn, M., Bowes, L., & David, S. (2004). Investigating subgroups in smoking cessation treatment response: Response to Perkins. NICOTINE & TOBACCO RESEARCH, 6(5), 865-867.

Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis
Munafo, M., Bradburn, M., Bowes, L., & David, S. (2004). Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. NICOTINE & TOBACCO RESEARCH, 6(5), 769-776.

Pharmacogenetics
David, S. P. (2004). Pharmacogenetics. PRIMARY CARE, 31(3), 543-?.

Evaluation of an educational intervention for medical students to promote competency in social and community determinants of health.
David SP., Taylor JS, Monroe A, Goldman R, Green AR, & Sagaties D. (2004). Evaluation of an educational intervention for medical students to promote competency in social and community determinants of health. ABSAME, 10(2).

Investigating subgroups in smoking cessation treatment response: Response to Perkins.
Munaf_ M, Bradburn M, Bowes L, & David S. (2004). Investigating subgroups in smoking cessation treatment response: Response to Perkins. Nicotine Tob Res, 6(5).

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
David, S. P., Niaura, R., Papandonatos, G. D., Shadel, W. G., Burkholder, G. J., & Walton, R. T. (2003). Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?. NICOTINE & TOBACCO RESEARCH, 5(6), 935-942.

Should we offer routine breast cancer screening with mammography?
David, S. P. (2003). Should we offer routine breast cancer screening with mammography?. AMERICAN FAMILY PHYSICIAN, 68(2), 260-262.

Genetic susceptibility to breast cancer: Teaching points
Gramling, R., & David, S. (2003). Genetic susceptibility to breast cancer: Teaching points. FAMILY MEDICINE, 35(7), 466-468.

Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels"
David, S. P., & Eaton, C. B. (2003). Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". NICOTINE & TOBACCO RESEARCH, 5(3), 397-399.

Are family physicians willing to use pharmacogenetics for smoking cessation therapy?
Stamp, M. J., & David, S. P. (2003). Are family physicians willing to use pharmacogenetics for smoking cessation therapy?. FAMILY MEDICINE, 35(2), 83-83.

Should we prescribe antibiotics for acute conjunctivitis?
David, S. P. (2002). Should we prescribe antibiotics for acute conjunctivitis?. American family physician, 66(9), 1649-1650.

Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?
David, S. P. (2002). Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?. AMERICAN FAMILY PHYSICIAN, 66(2), 245-246.

No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation
David, S. P., Johnstone, E., Griffiths, S. E., Murphy, M., Yudkin, P., & Walton, R. (2002). No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation. PHARMACOGENETICS, 12(3), 265-268.

Should we recommend nicotine replacement therapy?
David, S. P. (2001). Should we recommend nicotine replacement therapy?. AMERICAN FAMILY PHYSICIAN, 63(11), 2245-2247.

A civic role for physicians in the promotion of global tobacco control
David, S. P. (2001). A civic role for physicians in the promotion of global tobacco control. FAMILY PRACTICE, 18(1), 107-107.

Social marketing: Application to medical education
David, S. P., & Greer, D. S. (2001). Social marketing: Application to medical education. ANNALS OF INTERNAL MEDICINE, 134(2), 125-127.

Opioid antagonists for smoking cessation.
David, S., Lancaster, T., & Stead, L. F. (2001). Opioid antagonists for smoking cessation. Cochrane database of systematic reviews , (3), CD003086-?.

Smoking cessation for the primary care physician.
David SP. (2001). Smoking cessation for the primary care physician. Prim Care Rep., 7(24).

Media advocacy for the office-based teacher of family medicine
David, S. P. (2001). Media advocacy for the office-based teacher of family medicine. FAMILY MEDICINE, 33(1), 16-18.

International tobacco control: A focus group study of US anti-tobacco activists
David, S., DeJong, W., & Resnick, N. (2001). International tobacco control: A focus group study of US anti-tobacco activists. JOURNAL OF PUBLIC HEALTH POLICY, 22(4), 415-428.

Reflections from a rotation in Cambridge, England
David, S. P. (2000). Reflections from a rotation in Cambridge, England. FAMILY MEDICINE, 32(5), 310-312.

The Transatlantic Conference on Tobacco (TACT): a model for international tobacco policy activism.
David, S. P. (1998). The Transatlantic Conference on Tobacco (TACT): a model for international tobacco policy activism. Journal of cancer education , 13(4), 253-254.